Number of the records: 1  

Selective recognition of a saccharide-type tumor marker with natural and synthetic ligands: a new trend in cancer diagnosis

  1. 1.
    SYSNO ASEP0356081
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleSelective recognition of a saccharide-type tumor marker with natural and synthetic ligands: a new trend in cancer diagnosis
    Author(s) Kejík, Z. (CZ)
    Bříza, T. (CZ)
    Králová, Jarmila (UMG-J) RID
    Martásek, P. (CZ)
    Král, V. (CZ)
    Source TitleAnalytical and Bioanalytical Chemistry. - : Springer - ISSN 1618-2642
    Roč. 398, č. 5 (2010), s. 1865-1870
    Number of pages6 s.
    Languageeng - English
    CountryDE - Germany
    Keywordsextracellular-matrix components ; hepatocellular carcinoma ; breast cancer
    Subject RIVEB - Genetics ; Molecular Biology
    R&D ProjectsLC06077 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    GA203/09/1311 GA ČR - Czech Science Foundation (CSF)
    KAN200200651 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    CEZAV0Z50520514 - UMG-J (2005-2011)
    UT WOS000283244500005
    DOI10.1007/s00216-010-4124-7
    AnnotationIt is well known that saccharides and their glycoconjugates can have an important influence on various serious pathologic stages such as cancer. They can regulate tumor proliferation, invasion, hematogenous metastasis, and angiogenesis. These facts clearly show the importance of cancer saccharide recognition. In medicine, sensor analysis is one of the best methods for recognition and determination of biologically important analytes. The development and study of sensors for saccharide tumor markers can open a new way for their detection. Therefore, this review is focused on recognition of saccharide-based cancer markers by natural or synthetic selective ligands working as bio- and chemosensors. The design and application of these ligands for cancer diagnosis is a useful direction of research. Moreover, it also opens the possibility of using these agents for the targeted drug transport required for advanced anticancer therapy.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2011
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.